Tango Therapeutics Statistics
Total Valuation
TNGX has a market cap or net worth of $4.32 billion. The enterprise value is $3.37 billion.
| Market Cap | 4.32B |
| Enterprise Value | 3.37B |
Important Dates
The last earnings date was Monday, November 9, 2026, before market open.
| Earnings Date | Nov 9, 2026 |
| Ex-Dividend Date | n/a |
Share Statistics
TNGX has 169.46 million shares outstanding. The number of shares has increased by 36.56% in one year.
| Current Share Class | 169.46M |
| Shares Outstanding | 169.46M |
| Shares Change (YoY) | +36.56% |
| Shares Change (QoQ) | +16.05% |
| Owned by Insiders (%) | 1.06% |
| Owned by Institutions (%) | 110.33% |
| Float | 121.52M |
Valuation Ratios
| PE Ratio | n/a |
| Forward PE | n/a |
| PS Ratio | n/a |
| Forward PS | 911.63 |
| PB Ratio | 4.40 |
| P/TBV Ratio | 4.41 |
| P/FCF Ratio | n/a |
| P/OCF Ratio | n/a |
| PEG Ratio | n/a |
Enterprise Valuation
| EV / Earnings | n/a |
| EV / Sales | n/a |
| EV / EBITDA | n/a |
| EV / EBIT | n/a |
| EV / FCF | n/a |
Financial Position
The company has a current ratio of 39.45, with a Debt / Equity ratio of 0.03.
| Current Ratio | 39.45 |
| Quick Ratio | 38.85 |
| Debt / Equity | 0.03 |
| Debt / EBITDA | n/a |
| Debt / FCF | n/a |
| Interest Coverage | n/a |
Financial Efficiency
Return on equity (ROE) is -36.48% and return on invested capital (ROIC) is -23.68%.
| Return on Equity (ROE) | -36.48% |
| Return on Assets (ROA) | -22.97% |
| Return on Invested Capital (ROIC) | -23.68% |
| Return on Capital Employed (ROCE) | -22.67% |
| Weighted Average Cost of Capital (WACC) | 10.90% |
| Revenue Per Employee | n/a |
| Profits Per Employee | -$1.52M |
| Employee Count | 137 |
| Asset Turnover | n/a |
| Inventory Turnover | n/a |
Taxes
| Income Tax | -53,000 |
| Effective Tax Rate | n/a |
Stock Price Statistics
The stock price has increased by +232.46% in the last 52 weeks. The beta is 1.22, so TNGX's price volatility has been higher than the market average.
| Beta (5Y) | 1.22 |
| 52-Week Price Change | +232.46% |
| 50-Day Moving Average | 23.53 |
| 200-Day Moving Average | 22.90 |
| Relative Strength Index (RSI) | 57.02 |
| Average Volume (20 Days) | 4,192,868 |
Short Selling Information
The latest short interest is 48.24 million, so 28.47% of the outstanding shares have been sold short.
| Short Interest | 48.24M |
| Short Previous Month | 44.78M |
| Short % of Shares Out | 28.47% |
| Short % of Float | 39.70% |
| Short Ratio (days to cover) | 10.59 |
Income Statement
| Revenue | n/a |
| Gross Profit | -151.76M |
| Operating Income | -228.54M |
| Pretax Income | -208.05M |
| Net Income | -208.00M |
| EBITDA | -226.75M |
| EBIT | -228.54M |
| Earnings Per Share (EPS) | -$1.38 |
Balance Sheet
The company has $977.50 million in cash and $31.18 million in debt, with a net cash position of $946.32 million or $5.58 per share.
| Cash & Cash Equivalents | 977.50M |
| Total Debt | 31.18M |
| Net Cash | 946.32M |
| Net Cash Per Share | $5.58 |
| Equity (Book Value) | 980.17M |
| Book Value Per Share | 5.79 |
| Working Capital | 967.50M |
Cash Flow
In the last 12 months, operating cash flow was -$150.09 million and capital expenditures -$277,000, giving a free cash flow of -$150.36 million.
| Operating Cash Flow | -150.09M |
| Capital Expenditures | -277,000 |
| Depreciation & Amortization | 1.79M |
| Net Borrowing | n/a |
| Free Cash Flow | -150.36M |
| FCF Per Share | -$0.89 |
Margins
| Gross Margin | n/a |
| Operating Margin | n/a |
| Pretax Margin | n/a |
| Profit Margin | n/a |
| EBITDA Margin | n/a |
| EBIT Margin | n/a |
| FCF Margin | n/a |
Dividends & Yields
TNGX does not appear to pay any dividends at this time.
| Dividend Per Share | n/a |
| Dividend Yield | n/a |
| Dividend Growth (YoY) | n/a |
| Years of Dividend Growth | n/a |
| Payout Ratio | n/a |
| FCF Payout Ratio | n/a |
| Buyback Yield | -36.56% |
| Shareholder Yield | -36.56% |
| Earnings Yield | -5.41% |
| FCF Yield | -3.48% |
Analyst Forecast
The average price target for TNGX is $47.00, which is 84.31% higher than the current price. The consensus rating is "Strong Buy".
| Price Target | $47.00 |
| Price Target Difference | 84.31% |
| Analyst Consensus | Strong Buy |
| Analyst Count | 13 |
| Revenue Growth Forecast (3Y) | -54.64% |
| EPS Growth Forecast (3Y) | n/a |
Fair Value
There are several formulas that can be used to estimate the intrinsic value of a stock.
| Lynch Fair Value | n/a |
| Lynch Upside | n/a |
| Graham Number | n/a |
| Graham Upside | n/a |
| Graham Formula Value | n/a |
| Graham Formula Upside | n/a |
Stock Splits
This stock does not have any record of stock splits.
| Last Split Date | n/a |
| Split Type | n/a |
| Split Ratio | n/a |
Scores
TNGX has an Altman Z-Score of 29.45 and a Piotroski F-Score of 2.
| Altman Z-Score | 29.45 |
| Piotroski F-Score | 2 |